Biosensor analysis of anti-citrullinated protein/peptide antibody affinity

Analytical Biochemistry

Volumn 465, Issue , 2014, Pages 96-101

  Rossi, Giada ^a   Real Fernández, Feliciana ^b   Panza, Filomena ^c   Barbetti, Francesca ^b   Pratesi, Federico ^c   Rovero, Paolo ^a,b   Migliorini, Paola ^b,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Toscana Biomarkers Srl   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Affinity; Anti citrullinated protein peptide antibodies; Autoantibodies; Rheumatoid arthritis; Surface plasmon resonance

Indexed keywords

AMINO ACIDS; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; BIOSENSORS; BIOSYNTHESIS; DIAGNOSIS; DISEASES; DISSOCIATION; PLASMONS; PURIFICATION; SURFACE PLASMON RESONANCE; VIRUSES;

AFFINITY; AFFINITY CONSTANTS; AUTOANTIBODIES; BIOSENSOR ANALYSIS; DISSOCIATION RATES; MULTIPLE ANTIGEN PEPTIDES; PATHOGENIC POTENTIAL; RHEUMATOID ARTHRITIS;

PEPTIDES;

ANTIGEN; ARGININE; CITRULLINATED PEPTIDE ANTIBODY; HISTONE CITRULLINATED PEPTIDE 1; HISTONE H4; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIRAL CITRULLINATED PEPTIDE 1; VIRAL CITRULLINATED PEPTIDE 2; VIRUS PROTEIN; EBNA 1 PROTEIN (35-58), CITRULLINATED-; EBNA-2 PROTEIN (338-358), CITRULLINATED-; PEPTIDE FRAGMENT; VIRUS ANTIBODY;

ANTIBODY AFFINITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BIOSENSOR; CALCULATION; CONTROLLED STUDY; CROSS REACTION; DISSOCIATION; EPSTEIN BARR VIRUS; HUMAN; PROTEIN BINDING; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SURFACE PLASMON RESONANCE; SYNTHESIS; BIOASSAY; CHEMICAL MODEL; CHEMISTRY; IMMUNOLOGY; PROCEDURES;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; BIOLOGICAL ASSAY; CROSS REACTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MODELS, CHEMICAL; PEPTIDE FRAGMENTS; VIRAL PROTEINS;

EID: 84907258705     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2014.07.030     Document Type: Article

References (22)

1. G.J. Pruijn, A. Wiik, and W.J. van Venrooij The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis Arthritis Res. Ther. 12 2010 203
2. D. Aletaha, T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham, N.S. Birnbaum, G.R. Burmester, V.P. Bykerk, M.D. Cohen, B. Combe, K.H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J.M. Hazes, K. Hobbs, T.W. Huizinga, A. Kavanaugh, J. Kay, T.K. Kvien, T. Laing, P. Mease, H.A. Ménard, L.W. Moreland, R.L. Naden, T. Pincus, J.S. Smolen, E. Stanislawska-Biernat, D. Symmons, P.P. Tak, K.S. Upchurch, J. Vencovsky, F. Wolfe, and G. Hawker Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League against Rheumatism collaborative initiative Ann. Rheum. Dis. 69 2010 2010 1580 1588
3. H. Uysal, K.S. Nandakumar, C. Kessel, S. Haag, S. Carlsen, H. Burkhardt, and R. Holmdahl Antibodies to citrullinated proteins: molecular interactions and arthritogenicity Immunol. Rev. 233 2010 9 33
4. F. Pratesi, I. Dioni, C. Tommasi, M.C. Alcaro, I. Paolini, F. Barbetti, F. Boscaro, F. Panza, I. Puxeddu, P. Rovero, and P. Migliorini Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps Ann. Rheum. Dis. 73 2014 1414 1422
5. F. Pratesi, C. Tommasi, C. Anzilotti, D. Chimenti, and P. Migliorini Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis Arthritis Rheum. 54 2006 733 741
6. F. Pratesi, C. Tommasi, C. Anzilotti, I. Puxeddu, E. Sardano, G. Di Colo, and P. Migliorini Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies Clin. Exp. Immunol. 164 2011 337 345
7. M.A. van Boekel, E.R. Vossenaar, F.H. van den Hoogen, and W.J. van Venrooij Autoantibody systems in rheumatoid arthritis: specificity, sensitivity, and diagnostic value Arthritis Res. 4 2002 87 93
8. C. Clavel, L. Nogueira, L. Laurent, C. Iobagiu, C. Vincent, M. Sebbag, and G. Serre Induction of macrophage secretion of tumor necrosis factor through Fc receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen Arthritis Rheum. 58 2008 678 688
9. M.C. Lu, N.S. Lai, H.C. Yu, H.B. Huang, S.C. Hsieh, and C.L. Yu Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor production Arthritis Rheum. 62 2010 1213 1223
10. T. Dougan, J.B. Levy, A. Salama, A.J. George, and C.D. Pusey Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor Clin. Exp. Immunol. 128 2002 555 561
11. A. Rutgers, K.E. Meyers, G. Canziani, R. Kalluri, J. Lin, and M.P. Madaio High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to 3(IV)NC1 collagen Kidney Int. 58 2000 115 122
12. P. Achenbach, K. Koczwara, A. Knopff, H. Naserke, A.G. Ziegler, and E. Bonifacio Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes J. Clin. Invest. 114 2004 589 597
13. P. Suwannalai, H.U. Scherer, D. van der Woude, A. Ioan-Facsinay, C.M. Jol-van der Zijde, M.J. van Tol, J.W. Drijfhout, T.W. Huizinga, R.E. Toes, and L.A. Trouw Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens Ann. Rheum. Dis. 70 2011 373 379
14. P. Suwannalai, L.A. van de Stadt, H. Radner, G. Steiner, H.S. El-Gabalawy, C.M. Zijde, M.J. van Tol, D. van Schaardenburg, T.W. Huizinga, R.E. Toes, and L.A. Trouw Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis Arthritis Rheum. 64 2012 1323 1328
15. A.M. Lokate, J.B. Beusink, G.A. Besselink, G.J. Pruijn, and R.B. Schasfoort Biomolecular interaction monitoring of autoantibodies by scanning surface plasmon resonance microarray imaging J. Am. Chem. Soc. 129 2007 14013 14018
16. F. Real-Fernández, I. Passalacqua, E. Peroni, M. Chelli, F. Lolli, A.M. Papini, and P. Rovero Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance Sensors (Basel) 12 2012 5596 5607
17. K. Amara, J. Steen, F. Murray, H. Morbach, B.M. Fernandez-Rodriguez, V. Joshua, M. Engström, O. Snir, L. Israelsson, A.I. Catrina, H. Wardemann, D. Corti, E. Meffre, L. Klareskog, and V. Malmström Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition J. Exp. Med. 210 2013 445 455
18. J.J. van Beers, A. Willemze, J.J. Jansen, G.H. Engbers, M. Salden, J. Raats, J.W. Drijfhout, A.H. van der Helm-van Mil, R.E. Toes, and G.J. Pruijn ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression Arthritis Res. Ther. 15 2013 R140
19. G.A. Schellekens, B.A. de Jong, F.H. van den Hoogen, L.B. van de Putte, and W.J. van Venrooij Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J. Clin. Invest. 101 1998 273 281
20. M. Sebbag, N. Moinard, I. Auger, C. Clavel, J. Arnaud, L. Nogueira, J. Roudier, and G. Serre Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins Eur. J. Immunol. 36 2006 2250 2263
21. O. Snir, M. Widhe, C. von Spee, J. Lindberg, L. Padyukov, K. Lundberg, A. Engström, P.J. Venables, J. Lundeberg, R. Holmdahl, L. Klareskog, and V. Malmström Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles Ann. Rheum. Dis. 68 2009 736 743
22. Y. Allanore, J. Sellam, F. Batteux, C. Job Deslandre, B. Weill, and A. Kahan Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab Clin. Exp. Rheumatol. 22 2004 756 758